Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: Muskegon resident Pamela Anderson said that after hearing about numerous cases, she started a Facebook group about cancer deaths among people who live or have lived near the Butterworth landfill site in Grand Rapids. They plan to bring up the issue at a city commission meeting this week, the Grand Rapids Press reported . The group recently met with Kent County Health Department epidemiologist Brian Hartl, who advised them to collect more information on cancer rates in the area. "If there are rare forms of cancer, or cancers we're seeing affect a young population, it might trigger further investigation," Hartl said. But he cautioned that cancer is difficult to study, and that it can take years and multiple triggers to emerge. "Especially in small areas like a neighborhood or a block, it makes it challenging to connect it to environmental exposure," Hartl said. "Most cancers are due to lifestyle choices, not environmental factors." The Environmental Protection Agency estimates that theoretical cancer and health risks from the landfill exist, but that they're limited to regular direct contact with the waste over several decades. The agency conducted a site cleanup in 1999, and removed material contaminated with polychlorinated biphenyl and chromium. The EPA said there is no current exposure at the site. "A lot of those kids in the '60s and '70s used to play in the dump," said Shane Smith, who grew up down the street from Anderson in the Indiana Avenue neighborhood. "It was just starting to alarm to us, because my dad's entire generation passed away from cancer." Anderson said she's having the soil tested for contaminants at a home in the same neighborhood. ___ Information from: The Grand Rapids Press, http://www.mlive.com/grand-rapids Claim: Residents investigate cancer rates near Michigan landfill.

Answer: A group of residents is investigating cancer rates in a western Michigan neighborhood that's near a contaminated landfill classified as a Superfund site.

Question: Paragraph: Mentions cost for one year of Herceptin as $40,000-$50,000. Mentions quantitative benefit of 9 weeks of Herceptin vs. no Herceptin with certain chemotherapy. Also, while no women in the Herceptin group had cardiac failure at 3 years, the follow-up period may not be long-enough to determine the effects of chemotherapy and Herceptin on the heart. Mentions potential harms of Herceptin on the heart, especially when given after certain chemotherapy. The story does not mention that there were side effects with certain chemotherapy drugs and doses needed to be decreased during the course of the trial. One aspect of this trial focused on randomization of women with Her2/neu overexpression to 9 weeks of Herceptin or no Herceptin immediately following breast cancer surgery. The drug was given in conjunction with certain types of chemotherapy, but before radiation and chemotherapy regimens known to damage the heart. The journalist states the Herceptin was given "prior to chemotherapy", which is not completely accurate. There is an adequate mention of the study design and discussion of disease-free survival at 3 years follow-up. Good job putting the results into context of other trials, and into context of how this may or may not change providers' practice. The story could have better stated the limitations of analysis for such a small subgroup 116 in each arm. Appropriately discusses the percentage of women who are eligible for Herceptin due to overexpression of HER2/neu. The story would have been helped by some context for the risk these women face. As Herceptin is used earlier and earlier these women have less to gain because they have less risk to begin with. Relative risk reductions may be very high but the absolute is not as big. Sources in addition to study authors are cited. No mention that this trial was funded in part by pharmaceutical companies. Some study investigators also receive research funding drug companies. Other doctors cited express caution about the early results of Herceptin studies, so there is some balance to the piece. The women in this trial had undergone breast cancer surgery and those with ER+ tumors were taking Tamoxifen. This is not explicitly mentioned, only that treatment took place following surgery. Still OK. Herceptin is only FDA approved to treat advanced breast cancer, but is used in clinical trials in early-stage breast cancer. This is not mentioned in the story. Novel use of Herceptin for short-term treatment prior to anthracycline chemotherapy. No evidence that this story relies on a press release. Claim: Short stint of Herceptin holds promise for breast cancer

Answer: This story discusses the results of a recent study involving women with high-risk early breast cancer (node positive or >2cm, age younger than 66 there were 25 year olds on the trial). One aspect of this trial focused on the short-term use of Herceptin with chemotherapy. Women with overexpression of the HER2/neu gene, as measured by the CISH immunohistochemistry, were randomly assigned 9 weeks of Herceptin or no Herceptin immediately following breast cancer surgery and in conjunction with certain types of chemotherapy. This regimen of treatment differed from other trials in which Herceptin was given for 12 months following chemotherapy. In this study, the drug was given in conjunction with certain types of chemotherapy, but before radiation and chemotherapy regimens known to damage the heart. The journalist states the Herceptin was given "prior to chemotherapy," which is not completely accurate. Herceptin is only FDA approved to treat advanced breast cancer, but it is used in clinical trials in early-stage breast cancer. However, this is not mentioned in the story. There is adequate discussion of the study design and reporting of disease-free survival at 3 years follow-up. There was little discussion in the piece of the side effects of chemotherapy as reported in the trial, but the addition of Herceptin was the main focus of the story. While the journalist provides quantitative benefit of 9 weeks of Herceptin vs. no Herceptin, and notes no cardiac failure in the Herceptin group, the follow-up period of 3 years may not be long-enough to determine the effects of chemotherapy and Herceptin on the heart. Overall, the journalist did a good job describing the randomization, as well as putting the results into context of other trials, and into context of how this may or may not change providers' practice. The story could have better stated the limitations of analysis for such a small subgroup (116 in each arm). The small sample randomized to Herceptin certainly warrants more study, and although the relative benefits were large, these women still had fairly good recurrence free survival 80% w/o and 90% with so although it looks like that will translate to overall survival. The question for women with overexpression of the HER/neu gene is: How much do you want to do to avoid recurrence? Sources in addition to the study investigators are cited, which provides some balance to the piece, however, there is no mention that the trial was funded in part by pharmaceutical companies. Some study investigators also receive research funding from drug companies.

Question: Paragraph: In August 2020, amid an ongoing political crisis in the U.S. surrounding the Postal Service and mail-in ballots, readers asked Snopes to examine widespread claims that by texting "USPS" to the number 50409, an individual could send a letter to their local political representatives expressing support for the Postal Service. The COVID-19 coronavirus pandemic prompted millions of Americans to consider voting by mail, rather than in person, in 2020. But cuts at the Postal Service caused a slowdown in deliveries that meant millions of ballots were at risk of not being counted. U.S. President Donald Trump admitted he was pushing back against a fresh infusion of funding for the Postal Service, on the basis that mail-in ballots would disproportionately favor the presumptive Democratic presidential nominee Joe Biden, fueling a partisan battle, with Democrats demanding a properly funded, well-functioning Postal Service. On Aug. 15, 2020, Democratic Congressional candidate Allen Ellison tweeted that "If you text USPS to 50409 they will send letters to your senators and representative in support of the postal service. It literally takes under a minute." A similar exhortation posted on Facebook read: "Pushback pressure is working. Text USPS to 50409. This one-word text will automatically send a letter to your local representatives using Resistbot and urge them to take action. Thanks." The process is not quite as straightforward as described in the meme above, but it is true that texting "USPS" to 50409 does begin a relatively quick process under which, on your behalf, a bot sends letters to your federal political representatives based on the mailing address you provide. We tested the bot on Aug. 18, 2020, using the SMS utility on a cellphone and providing a real name and address in Pennsylvania's 8th Congressional District. (The creators of "Resistbot" state that the same process works on Apple's iMessage, Facebook's Messenger, Twitter, and the encrypted text message app Telegram.) The following is a step-by-step breakdown of how the bot works: First, the user texts "USPS" to 50409. The bot automatically and immediately replies, asking if the user wants to electronically sign a "Support the USPS" letter and send it to the user's political representatives. It also offers to show a sample of what the letter will look like: When the user replies with "SAMPLE," the bot replies with a link to a screenshot of the form letter and asks if the user would like to sign it: After the user confirms, the bot then asks for a first and last name and a mailing address: The bot adds the user's name to the petition and the mailing address allows it to identify the user's congressional district. The bot then automatically sends the letter via email to the corresponding members of the U.S. House of Representatives and Senate: Claim: "Texting ""USPS"" to 50409 engages a service called ""Resistbot"" and generates a letter of support for the Postal Service that is sent to a user's political representatives."

Answer:
A political crisis surrounding the Postal Service inspired some novel campaigning techniques in August 2020.